Loading data
QTTBNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 53.74 m USD | 0 USD | 1.16 m USD | 3.21 m USD | 33.97 m USD |
| Research and development expense | 19.16 m USD | 48.14 m USD | 31.73 m USD | 35.81 m USD | 93.09 m USD |
| Operating profit | 16.9 m USD | -66.1 m USD | -48.26 m USD | -39.23 m USD | -95.95 m USD |
| Profit before tax | — | — | -53.43 m USD | -42.75 m USD | -95.76 m USD |
| Income tax expense | 0 USD | 21 k USD | 318 k USD | 62 k USD | 0 USD |
| Net income (reported basis) | 29.8 m USD | -47.7 m USD | -53.7 m USD | -42.81 m USD | -95.76 m USD |
| Net income attributable to common shareholders | 29.82 k USD | -47.73 k USD | -53.74 k USD | -42.81 m USD | — |
| Basic earnings per share | 2.42 USD/share | -5.12 USD/share | -153.96 USD/share | -6.09 USD/share | -1.73 USD/share |
| Diluted earnings per share | 2.42 USD/share | -6.58 USD/share | -153.96 USD/share | -6.09 USD/share | -1.73 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.